Imprimed
ImpriMed, located in Palo Alto, CA, specializes in providing advanced diagnostic and treatment services for canine and feline lymphoma and leukemia. Utilizing AI-driven drug response predictions and comprehensive immunoprofiling, they enable veterinarians to make informed decisions regarding personalized cancer treatments for pets.
The company further enhances diagnostic accuracy with its Flow Cytometry PARR technology, which identifies lymphoma or leukemia subtypes, and offers additional services such as digital cytology. ImpriMed is committed to supporting veterinary professionals through innovative research and collaborative case studies in veterinary oncology.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.